ALD518 an asialated, humanized monoclonal antibody against interleukin-6. It is an investigational drug for cancer and rheumatoid arthritis due to its anti-inflammatory properties.
The relatively long half life of about 30 days should allow less frequent and subcutaneous injections.
It is made using yeast cells rather than the standard Chinese hamster ovary cells.
Adapted from the Wikipedia article ALD518, under the G. N. U. Free Documentation License. Please also see http://en.wikipedia.org/wiki
ALD518 – Introduction
ALD518 an asialated, humanized monoclonal antibody against interleukin-6. It is an investigational drug for cancer and rheumatoid arthritis due to its anti-inflammatory properties. The relatively long half life of about 30 days should allow less frequent and subcutaneous injections.






